PATENT CLAIM ANALYSIS

Application Number: 16215340
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "389000"]

Abstract:
Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.

Claim (Index 50):
The method according to  claim 25 , wherein the subject has received zero or one rounds of prior treatment with an anti-cancer agent, other than an androgen receptor inhibitor, for treatment of triple negative breast cancer.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.19231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14962864', '15075373', '13421367', '14759889', '12995450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.719591269661778
- 35 USC 102 Novelty (BERT): 0.7212779367247941
- Combined Prediction Score: 0.7197599363680797
- Mean Citation Score: 429.173646
- Max Citation Score: 886.7025
- Similarity Product: 755.4467450943588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test